| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
16353.5 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
8492.1 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ratio IC50 |
2.0 |
None |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
25118.86 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Liver microsomes |
Activity |
nan |
None |
10.1021/tx300075j |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscle-type nicotinic acetylcholine receptor |
EC50 |
30000.0 |
nM |
10.1021/jm970377o |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha2/beta4 |
IC50 |
3100.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha2/beta4 |
IC50 |
16000.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta2 |
IC50 |
280.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
100.0 |
nM |
10.1016/j.bmcl.2004.05.001 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
700.0 |
nM |
10.1016/j.bmc.2013.03.082 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
1400.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
3400.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
3800.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha3/beta4 |
Inhibition |
88.3 |
% |
10.1021/np3007414 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Concentration |
0.78 |
uM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
IC50 |
600.0 |
nM |
10.1016/j.bmc.2013.03.082 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta2 |
Inhibition |
91.8 |
% |
10.1021/np3007414 |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Concentration |
0.56 |
uM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Concentration |
1.2 |
uM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor; alpha4/beta4 |
Concentration |
3.1 |
uM |
10.1021/jm040219e |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
IC50 |
1800.0 |
nM |
10.1021/jm970377o |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-7 subunit |
IC50 |
12300.0 |
nM |
10.1021/jm040219e |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Potency |
10.0 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
1337.1 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Activity |
112.1 |
% |
10.1021/jm070524a |
| Homo sapiens |
Thrombopoietin |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Musca domestica |
Nicotinic acetylcholine receptor alpha 5 subunit |
Ki |
1000000.0 |
nM |
10.1584/jpestics.17.4_231 |
| Mus musculus |
Mus musculus |
Relative potency |
1.0 |
None |
10.1021/jm00107a019 |
| Mus musculus |
Mus musculus |
Relative potency |
1.4 |
None |
10.1021/jm00107a019 |
| Mus musculus |
Mus musculus |
Relative potency |
3.0 |
None |
10.1021/jm00107a019 |
| Plasmodium falciparum |
Plasmodium falciparum |
Accumulation coefficient |
45.0 |
None |
10.1021/jm011046l |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6000.0 |
nM |
10.1021/jm011046l |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
91400.0 |
nM |
10.1021/jm011046l |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
6012.0 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Reversal |
15.0 |
% |
10.1021/jm011046l |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Neuronal acetylcholine receptor |
EC50 |
200.0 |
nM |
10.1021/jm970377o |
| Rattus norvegicus |
Neuronal acetylcholine receptor |
Enhancement |
20.0 |
% |
10.1021/jm00147a021 |
| Rattus norvegicus |
Neuronal acetylcholine receptor |
Mean enhancement of binding |
16.4 |
None |
10.1021/jm00147a021 |
| Rattus norvegicus |
Rattus norvegicus |
HI |
110.0 |
None |
10.1021/jm00182a021 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.11 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1041 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.56 |
% |
10.6019/CHEMBL4495565 |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
IC50 |
596.0 |
nM |
10.1584/jpestics.20.49 |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
IC50 |
24700.0 |
nM |
10.1584/jpestics.20.49 |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
IC50 |
1000000.0 |
nM |
10.1584/jpestics.20.49 |
| Torpedo californica |
Acetylcholine receptor protein alpha chain |
Inhibition |
0.0 |
% |
10.1584/jpestics.20.49 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
No relevant target |
LogD |
-0.4 |
None |
10.1021/jm011046l |
| None |
No relevant target |
LogD7.4 |
-0.84 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
2.13 |
None |
10.1021/jm011046l |
| None |
No relevant target |
LogP |
3.53 |
None |
10.1021/jm00107a019 |
| None |
No relevant target |
pKa |
10.97 |
None |
10.1021/jm011046l |
| None |
No relevant target |
pKa |
11.2 |
None |
10.1021/jm070524a |
| None |
Unchecked |
Ac50 |
1.778 |
uM |
None |
| None |
Unchecked |
Ac50 |
4.467 |
uM |
None |
| None |
Unchecked |
Ac50 |
22.39 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
35.48 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
1778.3 |
nM |
None |
| None |
Unchecked |
AC50 |
4466.8 |
nM |
None |
| None |
Unchecked |
AC50 |
22390.0 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
35481.3 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
IC50 |
300.0 |
nM |
10.1016/j.ejmech.2015.06.039 |
| None |
Unchecked |
IC50 |
8980.0 |
nM |
10.1584/jpestics.20.57 |
| None |
Unchecked |
IC50 |
346000.0 |
nM |
10.1584/jpestics.20.57 |
| None |
Unchecked |
Imax |
91.0 |
% |
10.1016/j.bmc.2009.05.010 |
| None |
Unchecked |
Ki |
453000.0 |
nM |
10.1584/jpestics.17.4_231 |
| None |
Unchecked |
Potency |
1834.9 |
nM |
None |